Clive Maund
CliveMaund.com
Clive Maund has been president of www.clivemaund.com, a successful resource sector website, since its inception in 2003. He has 30 years' experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.
Recent Articles about Treatment.com AI Inc.
Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry? 12/20/2024
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors.
Is This AI Healthcare Stock Worth Being Overweight On? 10/09/2024
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) is a Strong Buy and worth being overweight on.
AI Health Stock Heading Higher Expert Says 07/02/2024
Technical Analyst Clive Maund gives an update on Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) as he believes "something is going on" and the stock may be heading higher.
AI Healthcare Stock Has Bullish Setup, Expert Says 04/22/2024
Technical Analyst Clive Maund reviews Treatment.com AI's charts and the recent influx of news to explain why he believes it is a Strong Buy.
This AI Co.'s Upside Potential Is Substantial, Analyst Says 02/16/2024
Technical Analyst Clive Maund reviews Treatment.com AI Inc.'s charts to explain why he believes it is currently a Strong Buy.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
